Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Filings indexed 2,862 across all filing types
Latest filing 2025-03-27 Annual Report
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
699400FG6E2AD50YHF38-2024-12-31-0-nl.xhtml
Annual Report Classification · 100% confidence The document is titled 'Jaarverslag 2024' (Annual Report 2024) for Galapagos NV. It contains comprehensive sections including a letter to stakeholders, business facts, financial highlights, sustainability disclosures, corporate governance, risk factors, and consolidated financial statements. It is clearly the full annual report, not an announcement or a summary, as it contains detailed financial data and operational reporting for the fiscal year 2024. FY 2024
2025-03-27 Dutch
699400FG6E2AD50YHF38-2024-12-31-0-nl (1).zip
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-03-27 Dutch
20-F Filing
Annual Report FY 2024
2025-03-27 English
6-K Filing
Regulatory Filings
2025-02-24 English
6-K Filing
Regulatory Filings
2025-02-18 English
Transparency Notification 2.14.25 redacted.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding the acquisition or disposal of voting securities, specifically detailing the crossing of a 5% threshold by Tang Capital Management and associated entities. It follows the standard regulatory format for major shareholding notifications (transparency declarations), which requires disclosure of voting rights and equivalent financial instruments. This aligns perfectly with the definition of a Major Shareholding Notification.
2025-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.